Hashem Alsaab
Hashem Alsaab
Assistant Professor of Pharmaceutics and Pharmaceutical Technology at Taif University
Verified email at wayne.edu - Homepage
Cited by
Cited by
PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome
HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise, SK Kashaw, AK Iyer
Frontiers in pharmacology 8, 561, 2017
Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery
AK Sharma, A Gothwal, P Kesharwani, H Alsaab, AK Iyer, U Gupta
Drug Discovery Today 22 (2), 314-326, 2017
Advances in antibody–drug conjugates: a new era of targeted cancer therapy
S Sau, HO Alsaab, SK Kashaw, K Tatiparti, AK Iyer
Drug discovery today 22 (10), 1547-1556, 2017
Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy
JM Wickens, HO Alsaab, P Kesharwani, K Bhise, MCIM Amin, RK Tekade, ...
Drug discovery today 22 (4), 665-680, 2017
Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment
S Sau, HO Alsaab, K Bhise, R Alzhrani, G Nabil, AK Iyer
Journal of Controlled Release 274, 24-34, 2018
Folic acid conjugated polymeric micelles loaded with a curcumin difluorinated analog for targeting cervical and ovarian cancers
D Luong, P Kesharwani, HO Alsaab, S Sau, S Padhye, FH Sarkar, AK Iyer
Colloids and Surfaces B: Biointerfaces 157, 490-502, 2017
Nanomedicine for cancer diagnosis and therapy: advancement, success and structure–activity relationship
K Bhise, S Sau, H Alsaab, SK Kashaw, RK Tekade, AK Iyer
Therapeutic delivery 8 (11), 1003-1018, 2017
CD44 directed nanomicellar payload delivery platform for selective anticancer effect and tumor specific imaging of triple negative breast cancer
Z Wang, S Sau, HO Alsaab, AK Iyer
Nanomedicine: nanotechnology, biology and medicine 14 (4), 1441-1454, 2018
Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages
HO Alsaab, S Sau, RM Alzhrani, VT Cheriyan, LA Polin, U Vaishampayan, ...
Biomaterials 183, 280-294, 2018
Folate decorated nanomicelles loaded with a potent curcumin analogue for targeting retinoblastoma
H Alsaab, RM Alzhrani, P Kesharwani, S Sau, SHS Boddu, AK Iyer
Pharmaceutics 9 (2), 15, 2017
PDL-1 antibody drug conjugate for selective chemo-guided immune modulation of cancer
S Sau, A Petrovici, HO Alsaab, K Bhise, AK Iyer
Cancers 11 (2), 232, 2019
Organogels in drug delivery: a special emphasis on pluronic lecithin organogels
H Alsaab, SP Bonam, D Bahl, P Chowdhury, K Alexander, SHS Boddu
Journal of Pharmacy & Pharmaceutical Sciences 19 (2), 252-273, 2016
A CARP-1 functional mimetic loaded vitamin E-TPGS micellar nano-formulation for inhibition of renal cell carcinoma
VT Cheriyan, HO Alsaab, S Sekhar, C Stieber, P Kesharwani, S Sau, ...
Oncotarget 8 (62), 104928, 2017
Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma
S Yousef, HO Alsaab, S Sau, AK Iyer
Heliyon 4 (12), e01071, 2018
A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy
S Sau, K Tatiparti, HO Alsaab, SK Kashaw, AK Iyer
Drug discovery today 23 (7), 1344, 2018
Anti-inflammatory effects of a novel ricinoleic acid poloxamer gel system for transdermal delivery
SHS Boddu, H Alsaab, S Umar, SP Bonam, H Gupta, S Ahmed
International journal of pharmaceutics 479 (1), 207-211, 2015
Combination of vancomycin and cefazolin lipid nanoparticles for overcoming antibiotic resistance of MRSA
K Bhise, S Sau, R Kebriaei, SA Rice, KC Stamper, HO Alsaab, MJ Rybak, ...
Materials 11 (7), 1245, 2018
Progress in clinical trials of photodynamic therapy for solid tumors and the role of nanomedicine
HO Alsaab, MS Alghamdi, AS Alotaibi, R Alzhrani, F Alwuthaynani, ...
Cancers 12 (10), 2793, 2020
Pregabalin: potential for addiction and a possible glutamatergic mechanism
YS Althobaiti, A Almalki, H Alsaab, W Alsanie, A Gaber, Q Alhadidi, ...
Scientific reports 9 (1), 1-8, 2019
A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancers
VT Cheriyan, H Alsaab, S Sekhar, J Venkatesh, A Mondal, I Vhora, S Sau, ...
Oncotarget 9 (51), 29680, 2018
The system can't perform the operation now. Try again later.
Articles 1–20